Cost-effectiveness analysis of enzalutamide for patients with chemotherapy-naïve metastatic castration-resistant prostate cancer in Japan

BACKGROUND: We aimed to evaluate cost-effectiveness of enzalutamide in chemotherapy-naïve metastatic castration-resistant prostate cancer patients in Japan. METHODS: A Markov model was developed to capture time spent by patients in various health states: stable, progression and death. Abiraterone ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Okumura, Hiroyuki, Inoue, Sachie, Naidoo, Shevani, Holmstrom, Stefan, Akaza, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326386/
https://www.ncbi.nlm.nih.gov/pubmed/34037235
http://dx.doi.org/10.1093/jjco/hyab071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326386/
https://www.ncbi.nlm.nih.gov/pubmed/34037235
http://dx.doi.org/10.1093/jjco/hyab071

Ejemplares similares